Peptide Encyclopedia / SNAP-8
EncyclopediaSNAP-8 is a synthetic octapeptide and elongated version of Argireline, applied topically to soften expression lines. It is reported to act at the SNARE protein complex, competing with SNAP-25 to reduce the signaling behind facial muscle contraction. It sells as a cosmetic ingredient, not an FDA-approved drug, and efficacy data comes mostly from manufacturer and small cosmetic studies. Below you'll find reported use, safety, and legal status. Educational only, not medical advice.
| Category | Cosmetic / Skin |
| Regulatory status | Not an FDA-approved drug. |
A synthetic octapeptide and elongated analog of Argireline (acetyl hexapeptide) used topically; reported to modulate the SNARE protein complex (competing with SNAP-25) to reduce catecholamine/acetylcholine release at the neuromuscular junction, thereby reducing expression-line muscle contraction in the skin.
Not applicable/uncertain; used as a topical cosmetic ingredient rather than a systemic drug, with negligible expected systemic absorption.
Not an FDA-approved drug. Marketed as a cosmetic ingredient in the US (cosmetics are regulated by FDA but not pre-approved); it makes no approved drug claims.
Generally considered well tolerated topically; possible local irritation. Anti-wrinkle efficacy claims are based largely on manufacturer and small studies and are modest.
Manufacturer and small cosmetic studies; limited independent peer-reviewed efficacy data.
PepWise is an informational and educational tracking tool, not medical advice and not a medical device. SNAP-8 may be experimental, restricted, or prescription-only; many research peptides are not FDA-approved. Consult a licensed healthcare provider before starting, changing, or stopping any protocol. Operated by STC Consulting, Inc.
